The upcoming report from Tempus AI (TEM) is expected to reveal quarterly loss of -$0.02 per share, indicating an increase of 88.9% compared to the year-ago period. Analysts forecast revenues of $366.8 million, representing an increase of 82.8% year over year.
The consensus EPS estimate for the quarter has undergone an upward revision of 2.5% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
In light of this perspective, let's dive into the average estimates of certain Tempus metrics that are commonly tracked and forecasted by Wall Street analysts.
The collective assessment of analysts points to an estimated 'Net Revenue- Data and services' of $98.70 million. The estimate suggests a change of +23% year over year.
According to the collective judgment of analysts, 'Net Revenue- Genomics' should come in at $262.05 million. The estimate indicates a year-over-year change of +117.6%.
Analysts' assessment points toward 'Non-GAAP Gross Profit- Genomics' reaching $159.93 million. The estimate is in contrast to the year-ago figure of $59.76 million.
It is projected by analysts that the 'Non-GAAP Gross Profit- Data and Services' will reach $73.47 million. The estimate compares to the year-ago value of $64.40 million.
View all Key Company Metrics for Tempus here>>>Over the past month, shares of Tempus have returned -14% versus the Zacks S&P 500 composite's -0.8% change. Currently, TEM carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpTempus AI, Inc. (TEM) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
